IMCS (Integrated Micro-Chromatography Systems, Inc.) is closely monitoring all Coronavirus (COVID-19) information by tracking guidance from the U.S. Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO).
We understand the impact and importance of keeping a continuous supply chain in the toxicology/drug testing and biopharma industries. Our company maintains ISO 9001:2015 manufacturing standards and all of our tips and enzymes are manufactured in-house at our facility in Irmo, South Carolina.
This event does not significantly impact IMCS or its supply chain, nor do we anticipate delays in processing orders. We remain committed to providing the best quality products to our customers throughout this situation.
Click here to read and download our official statement regarding COVID-19.
IMCS collaborates with Hamilton Robotics for Automated MAM sample prep
